ISEC Healthcare Ltd · SGX:40T
ISEC Healthcare — FY2016 Earnings Presentation
24 slides from ISEC Healthcare's earnings presentation, Feb 23, 2017
Slide 1: Corporate Presentation
Corporate Presentation 12 months ended 31 December 2016 Page 0
Slide 2: Disclaimer
This presentation has been prepared by the Company and its contents have been reviewed by the Company’s sponsor, PrimePartners Corporate Finance Pte. Ltd. (the “Sponsor”), for compliance with the Singapore Exchange Securities Trading Limited (the “SGX-ST”) Thank You Listing Manual Section B: Rules o
Slide 3: Table of Content
Table of Content Business Overview Industry Overview Business Strategy and Expansion Plans Corporate Developments and Use of Proceeds 12 months ended 31 December 2016 Financial Highlights Page 2
Slide 4: Business Overview
Thank You Business Overview Page 3 3
Slide 5: Business Overview
Business Overview • Specialised Health Services – Medical eye care service provider • ISEC is a comprehensive medical eye care service provider, with ambulatory surgical centres in Malaysia (Kuala Lumpur, Penang & Malacca) and provides specialist medical ophthalmology services to Lee Hung Ming Eye C
Slide 6: Competitive Strengths of the Group
Business Overview Competitive Strengths of the Group 1 Highly qualified and experienced specialist doctors 6 Business model aligns the 2 interests of our High quality and specialist doctors with comprehensive range of our Group and eye care services Shareholders 5 Ability to replicate our 3 Well pos
Slide 7: Industry Overview
Thank You Industry Overview Page 6 6
Slide 8: Key Drivers for Private Ophthalmology
Industry Overview Key Drivers for Private Ophthalmology AGEING POPULATION with large elderly 25.9% of population in Malaysia above 40 years old in 2013, expected to patient group suffering from cataract, grow at CAGR of 1.7% from 2013 to 2018 glaucoma, AMD, dry eyes or vitreoretinal diseases as th
Slide 9: Key Drivers for Private Ophthalmology (cont'd)
Industry Overview Key Drivers for Private Ophthalmology (cont’d) Medical tourism based healthcare expenditure forecast to grow at 26.7% GOVERNMENT SUPPORT IN PROMOTING CAGR from 2009 to 2018 in Malaysia MEDICAL TOURISM leading to generation of additional demand for medical services Medical touri
Slide 10: Business Strategy and Expansion Plans
Thank You Business Strategy And Expansion Plans Page 9 9
Slide 11: Our Business Strategies
Our Business Strategies To reach more patients in locations where we currently Growing the ISEC operate, as well as new locations such as major cities or Brand and locations in Peninsular Malaysia, East Malaysia and Singapore Expanding into To expand via setting up of subsidiaries, JV, expand ex
Slide 12: Expansion Plans
Expansion Plans Business expansion in the Asia pacific region (including Malaysia Malaysia & and Singapore) Singapore Target Countries Page 11
Slide 13: Corporate Developments and Use of Proceeds
Thank You Corporate Developments and Use of Proceeds Page 12 12
Slide 14: Corporate Developments
Corporate Developments 1 December 2016 – Completed the acquisition of 100% of the shares of JL Medical (Bukit Batok) Pte. Ltd., JL Medical (Sembawang) Pte. Ltd., JL Medical (Woodlands) Pte. Ltd. and JL Medical (Yew Tee) Pte. Ltd. (collectively, “JLM Companies”) by ISEC Healthcare Ltd. Unless otherwi
Slide 15: Corporate Developments (cont'd)
Corporate Developments 1 December 2016 – Completion of the acquisition of 100% of the shares of the JLM Companies by ISEC Healthcare Ltd. (Cont’d) Summary of the acquisition (Cont’d) • Each of the Vendors had provided a profit guarantee for the benefit of the Company in respect of the audited profit
Slide 16: Corporate Developments (cont'd)
Corporate Developments 1 December 2016 – Completion of the acquisition of 100% of the shares of the JLM Companies by ISEC Healthcare Ltd. (Cont’d) Whitewash Resolution and Whitewash Waiver • The Company had on 7 October 2016 obtained approval from independent Shareholders for the Proposed Whitewash
Slide 17: Use of Proceeds
Use of Proceeds As at 23 February 2017 Amount allocated pursuant to reallocation of Use of proceeds Amount unutilised listing Amount allocated expenses utilised Balance S$’000 S$’000 S$’000 S$’000 Business expansion in Asia Pacific region (including Malaysia and 13,800 300 (12,565) (N1) 1,535 Singap
Slide 18: 12 Months Financial Highlights
Thank You 12 Months Financial Highlights for the period ended 31 December 2016 Page 17 17
Slide 19: Revenue
Revenue SGD’mil FY2016 vs FY2015 Group revenue was higher. The increase was attributable to higher revenue contribution from Malaysia operations. Southern Specialist Eye Centre (“SSEC”) which was acquired on 8 December 2015 contributed S$4.2 million to the Group’s revenue in FY2016. Revenue from S
Slide 20: Revenue – Malaysia
Revenue – Malaysia RM’mil SGD’mil 31.1% 24.4% Revenue from Malaysia operations in Ringgit Malaysia (“RM”) increased from RM59.4 million in FY2015 to RM77.9 million in FY2016, up 31.1% mainly due to increased number of patients visits in ISEC KL and ISEC Penang and the inclusion of results from SSE
Slide 21: EBITDA and Profit After Tax (PAT)
Earnings Before Interest Tax Depreciation and Amortisation (EBITDA) and Profit After Tax (PAT) SGD’000 EBITDA was S$9.4 million in FY2016 as compared to S$5.4 million in FY2015 mainly due to contribution from SSEC for the full 12 months in FY2016, increased patient visits in Malaysia operations an
Slide 22: Cash Position
Cash Position Total cash and cash equivalents Unutilised IPO proceeds Cash balances SGD’mil Total cash and cash equivalents as at 31 December 2016 was S$20.4 million. No debts. Cash balances (exclude unutilised IPO proceeds) increased from S$16.1 million as at 31 Dec 2015 to S$18.9 million as at
Slide 23: Statement of Financial Position
Statement of Financial Position S$’000 30 December 31 December 2016 2015 Key Assets Plant and equipment 3,967 3,639 Intangible assets 39,111^ 25,162 Trade and other receivables 2,171 1,905 Cash and cash equivalents 20,376 24,924 Key Liabilities Trade and other payables 4,919 3,410 Equity Total equit
Slide 24: Thank You
Thank You Thank You Page 23 23